Concepts (47)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nasopharyngeal Neoplasms | 1 | 2024 | 17 | 0.960 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 88 | 0.860 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 127 | 0.850 |
Why?
|
| Interleukin-2 | 1 | 2022 | 89 | 0.790 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 92 | 0.770 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 84 | 0.770 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 358 | 0.690 |
Why?
|
| Neoplasms | 1 | 2022 | 1103 | 0.400 |
Why?
|
| Fibronectins | 2 | 2021 | 66 | 0.370 |
Why?
|
| Antibodies, Monoclonal | 2 | 2024 | 290 | 0.340 |
Why?
|
| Cell Hypoxia | 2 | 2022 | 58 | 0.250 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 2231 | 0.200 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 357 | 0.190 |
Why?
|
| Cobalt | 1 | 2020 | 26 | 0.190 |
Why?
|
| Cell Movement | 2 | 2021 | 571 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 36 | 0.180 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 80 | 0.180 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 68 | 0.180 |
Why?
|
| Cancer Vaccines | 1 | 2017 | 21 | 0.150 |
Why?
|
| Lymphoma | 1 | 2017 | 38 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 159 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2017 | 95 | 0.140 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 186 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2022 | 1908 | 0.110 |
Why?
|
| Humans | 5 | 2024 | 37093 | 0.110 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2010 | 5 | 0.090 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2010 | 29 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 61 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 173 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2021 | 176 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2021 | 399 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 661 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 115 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 893 | 0.040 |
Why?
|
| Receptors, OX40 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Remission Induction | 1 | 2017 | 16 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2021 | 384 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2017 | 77 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 227 | 0.040 |
Why?
|
| Mice | 2 | 2017 | 5913 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1609 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1371 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2010 | 43 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 185 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 15081 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 1095 | 0.020 |
Why?
|
| Female | 1 | 2017 | 20969 | 0.010 |
Why?
|